Healthcare Realty Trust Incorporated Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Healthcare Realty Trust Incorporated Common Stock trades at $17 (market cap $5.90B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.39B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Healthcare Realty Trust Incorporated Common Stock pays a 5.57% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthcare Realty Trust Incorporated Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 6 Days on average.
| HR | IBRX | |
|---|---|---|
Market Cap | $5.90B | $10.39B |
Volume | 4,466,610 | 11,509,049 |
Sector | Real Estate | Health |
52-Week High | $21.87 | $11.55 |
52-Week Low | $16.34 | $1.98 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $10.29B | $10.84B |
Dividend Yield | 5.57% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ImmunityBio (IBRX) trades at $9.80, down 3.16% on the day, amid a bullish technical setup and strong analyst support. The company reported revenue growth to $166 million in 2026 but remains deeply unprofitable with a net loss of $992 million. Recent FDA approval expansion for ANKTIVA in bladder cancer and high-profile executive appointments signal operational momentum, though cash burn remains a concern with negative operating cash flow.
Outlook is cautiously optimistic given the unanimous buy ratings and regulatory milestones, but investment carries high risk due to persistent losses, heavy reliance on financing, and competitive pressures. The stock's trajectory hinges on successful commercialization and pipeline execution to achieve profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Healthcare Realty Trust Incorporated is a real estate investment trust that owns and manages outpatient medical facilities and on-campus medical office buildings across US, leasing space to physician groups, hospitals, and health systems.
Read more on HR →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →